Position in YCBD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,858
-$3,162 QoQ
Shares Held
5,200
0.0% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in YCBD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HARBOUR INVESTMENTS, INC. holds $1,485,705 across 37 Drug Manufacturers - Specialty & Generic names. YCBD ranks #21 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RMTI |
Rockwell Medical, Inc.
|
33,674 | $299,698 | |
| 2 | ZTS |
Zoetis Inc.
|
2,164 | $255,806 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
10,014 | $207,890 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
8,107 | $150,141 | |
| 5 | VTRS |
Viatris Inc
|
10,434 | $140,963 | |
| 6 | HROW |
Harrow, Inc.
|
1,970 | $69,462 | |
| 7 | HLN |
Haleon plc
|
5,879 | $58,848 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,553 | $46,776 |
All Filings in YCBD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,858 | 5,200 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,020 | 5,200 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $6,292 | 5,200 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,638 | 5,200 | Shares | Sole | 2025-07-28 | |
| No filing history on record for this holder in this stock. | ||||||